Filter
4030
Filtered Results: 4030
Text search:
supply
of
medicines
Featured
Recommendations
419
New Publications
1197
Language
Document type
No document type
2156
Studies & Reports
714
Guidelines
565
Manuals
219
Strategic & Response Plan
190
Training Material
59
Fact sheets
58
Situation Updates
45
Resource Platforms
9
Brochures
6
Infographics
4
Online Courses
4
App
1
Countries / Regions
India
226
Global
148
Kenya
133
Ethiopia
123
Uganda
102
Sierra Leone
92
South Africa
89
Nepal
88
Liberia
86
Nigeria
86
Malawi
72
Myanmar / Burma
68
Bangladesh
67
Zambia
66
Tanzania
66
Western and Central Europe
65
Africa
62
Syria
58
Ghana
57
Ukraine
54
Rwanda
49
Latin America and the Carribbean
44
Philippines
43
South–East Asia Region
34
Congo, Democratic Republic of
33
Zimbabwe
33
Namibia
33
East and Southern Africa
26
Mozambique
25
Lesotho
25
Asia
25
Eastern Europe
25
Senegal
23
Guinea
22
Haiti
21
Yemen
21
Venezuela
21
Burkina Faso
20
South Sudan
19
West and Central Africa
19
Cambodia
18
Botswana
18
Middle East and North Africa
18
Brazil
17
Eastern Europe and Central Asia
17
Russia
17
Indonesia
16
Cameroon
15
Pakistan
14
Sudan
14
Afghanistan
13
Madagascar
12
Western Pacific Region
11
Lebanon
10
Eswatini/ Swaziland
10
Colombia
10
Moldova
10
Benin
9
Georgia
9
Somalia
7
Jordan
7
Thailand
7
Central African Republic
7
Iraq
6
Germany
6
North Macedonia
6
Sri Lanka
6
Albania
6
Tajikistan
6
Vietnam
6
Turkey
5
Peru
5
Laos
5
Kyrgyzstan
5
USA
4
China
4
Poland
4
Palestine
4
Kazakhstan
4
Turkmenistan
4
United Kingdom
4
Mali
3
Saudi Arabia
3
Gambia
3
Hungary
3
Burundi
3
Ecuador
3
Bolivia
3
Libya
3
Mexico
3
Bhutan
3
Timor Leste/ East Timor
3
Jamaica
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Chad
2
Papua New Guinea
2
Argentina
2
Serbia
2
Greece
2
Angola
2
Chile
2
Paraguay
2
Fiji
2
Armenia
2
Southern Africa
2
Canada
2
Romania
2
Iran
2
Uzbekistan
2
Portugal
2
Bosnia and Herzegovina
2
Niger
1
Togo
1
Egypt
1
Malaysia
1
Mauritania
1
Other region
1
Solomon Islands
1
Bulgaria
1
Estonia
1
Australia
1
North America
1
Gabon
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
South Korea
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1784
Clinical Guidelines
340
Public Health
200
Women & Child Health
194
Key Resources
171
Pharmacy & Technologies
68
Capacity Building
66
Annual Report MEDBOX
2
Toolboxes
COVID-19
404
HIV
277
TB
215
AMR
176
Pharmacy
162
Mental Health
159
Conflict
133
Planetary Health
125
Caregiver
116
Rapid Response
106
Ebola
95
NTDs
85
NCDs
69
Natural Hazards
64
Global Health Education
60
Disability
56
Refugee
50
Health Financing Toolbox
34
Specific Hazards
23
Cholera
22
Polio
14
Zika
9
Social Ethics
8
Typhoon
1
Health Financing
1
The WHO Trauma Bag 2021 is intended to provide the resources needed to care for care of acutely ill and injured patients in hospital emergency units, field hospitals or clinics providing acute care. The Trauma Bag may also be applicable in prehospi...
Safe disposal of children’s feces is as essential as the safe disposal of adults’ feces. Th is brief provides an overview of the available data...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantit...
Healthy communities rely on well-functioning ecosystems. They provide clean air, fresh water, medicines and food security. They also limit disease and stabilize the climate. But biodiversity loss is happening at unprecedented rates, impacting human ...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV se...
The resources provide both the older as well as the updated Operational Guidelines for antiretroviral therapy centres, including administrative issues, functions and establishment of centres, reporting and recording tools, measures to improve retent...
WHO's Severe acute malnutrition with medical complications kit (SAM/MC) kit is a standard kit designed to provide medical treatment for 50 children under five suffering from severe malnutrition with medical complications. The SAM/MC kit includes antibiotics, antifungal, de-worming, antimalarial and ...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines up...
7 June 2022. To treat complications associated with measles: severe complications with module 1 (50 cases) and mild complications with module 8 (20 cases).
The new measles kit 2021 is designed to prepare for and support the treatment of non-severe ...
Humanitarian emergencies result in a breakdown of critical health-care services and often make vulnerable communities dependent on external agencies for care. In resource-constrained settings, this may occur against a backdrop ... extreme poverty, malnutrition, insecurity, low literacy and poor infrastructure. Under these circumstances, providing food, water and shelter and limiting communicable disease outbreaks become primary concerns. Where effective and safe vaccines are available to mitigate the risk of disease outbreaks, their potential deployment is a key consideration in meeting emergency health needs. Ethical considerations are crucial when deciding on vaccine deployment. Allocation of vaccines in short supply, target groups, delivery strategies, surveillance and research during acute humanitarian emergencies all involve ethical considerations that often arise from the tension between individual and common good. The authors lay out the ethical issues that policy-makers need to bear in mind when considering the deployment of mass vaccination during humanitarian emergencies, including beneficence (duty of care and the rule of rescue), non-maleficence, autonomy and consent, and distributive and procedural justice
This second edition of the “living paper” contributes to the global knowledge on how countries are responding to the pandemic by documenting real-time actions in a key area of response – that ...
Countries can use this tool to collect in-depth facility inventories of biomedical equipment re-allocation, procurement and planning for COVID-19 case management. The survey assesses quantified availability and the causes for non-functioning ... different sources of oxygen delivery and supply systems to the patient in order to determine priorities and re-allocation requirements in accordance with needs.
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system ... indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and performance of key national pharmaceutical structures and processes. Level II indicators measure key outcomes of these structures and processes in the areas of access, product quality and rational use. These indicators can be used to assess progress over time; to compare situations between countries; and to reassess and prioritize efforts based on the results.
This Fact Book gives the results of the assessment of Level I indicators conducted in 2003 and of Level II indicator surveys conducted between 2002 and 2004
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient ...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology,...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start ... the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future supply security. In 2021, the AU set a target to produce and supply more than 60% of the vaccine doses on the continent by 2040.
In the last 18 months alone, more than 30 new African manufacturing projects have been announced and estimates indicate that the African vaccine market across all existing and projected novel products could range between US$ 2.8 billion and US$ 5.6 billion by 2040*, demonstrating the potential for a thriving regional industry to emerge.
Accessed on 31.03.2023
COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medici... (MAM) and inform Neglected Tropical Disease (NTD) policy through an enhanced community engagement strategy. A situational analysis conducted in 2016 identified community engagement as a
bottleneck to achieving equitable coverage of MAM within different and emerging contexts (border, migrant, rural and urban) of Nigeria, related to programmatic, social, political and environmental changes over time See: (Dean et al., 2019), (Oluwole et al., 2019) and (Adekeye et al., 2019)
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, peopl...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak o... coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that the blood services should take to mitigate the potential risk to the safety and sufficiency of the blood supplies during the pandemic.
It should be read in conjunction with WHO Guidance for National Blood Services on Protecting the Blood Supply During Infectious Disease Outbreaks, which provides general guidance on the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply.
